Sutton Place Investors’s Bristol-Myers Squibb BMY Stock Holding History

Sutton Place Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,916	Closed	-$448K	–	111
2024 Q4	$448K	Buy	7,916 +273	+4%	+$15.3K	0.26%	85
2024 Q3	$395K	Buy	7,643 +317	+4%	+$14.9K	0.24%	86
2024 Q2	$304K	Sell	7,326 -13,700	-65%	-$613K	0.2%	89
2024 Q1	$1.14M	Buy	21,026 +6,402	+44%	+$326K	0.56%	50
2023 Q4	$750K	Buy	+14,624	New	+$768K	0.54%	63

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sutton Place Investors's BMY Position: Q1 2025 in Review

Sutton Place Investors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 7,916 shares — an estimated $448K sold.

Sutton Place Investors first reported a position in BMY in Q4 2023 and held it in 5 quarters. The position peaked at $1.14M in Q1 2024. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Sutton Place Investors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Sutton Place Investors sold 7,916 Bristol-Myers Squibb shares in Q1 2025, an estimated $448K.
Sutton Place Investors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 5 quarters.
Sutton Place Investors's Bristol-Myers Squibb position peaked at $1.14M in Q1 2024.
2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Sutton Place Investors's 13F filing for Q1 2025, filed 29 Apr 2025.